Valeant Pharma (VRX) sued in New York Federal court over alleged overcharges - Reuters

(Updated - August 29, 2016 2:01 PM EDT)

Valeant Pharma (NYSE: VRX) was sued in New York Federal court over alleged overcharges, according to Reuters. The lawsuit was brought on behalf of so-called third party payors over alleged overcharges from January 2013 to October 2015.

Plaintiffs include New York hotel trade group's health benefits fund, and detectives endowment association of New York City, the report noted.

The lawsuit accuses Valeant of violating U.S. racketeer influenced and corrupt organizations act, or RICO, and seeks class action status, unspecified compensatory and triple damages.

You May Also Be Interested In

• US DoJ to Decide by as Soon as Late May Whether Boeing Violated Prosecution Deal - Reuters
• Trump Media & Technology Group (DJT) Provides Additional Information to DJT Investors on Short Selling
• General Motors (GM) CFO: Expect to return to profits in Q2 in China